Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 1606 AL 1620

Multiscale imaging characterization of dopamine transporter knockout mice reveals regional alterations in spine density of medium spiny neurons

Berlanga ML, Price DL, Phung BS, Giuly R, Terada M, Yamada N, Cyr M, Caron MG, Laakso A, Martone ME, Ellisman MH.

Brain Res. 2011 May 16;1390:41-9. doi: 10.1016/j.brainres.2011.03.044. Epub 2011 Mar 24.

[Dietary flavonoids and human health]

Stoclet JC, Schini-Kerth V.

Ann Pharm Fr. 2011 Mar;69(2):78-90. doi: 10.1016/j.pharma.2010.11.004. Epub 2011 Mar 1.

Autonomic dysfunction in neurodegenerative dementias

Idiaquez J, Roman GC.

J Neurol Sci. 2011 Jun 15;305(1-2):22-7. doi: 10.1016/j.jns.2011.02.033. Epub 2011 Mar 25.

Knowing me, knowing you: can a knowledge of risk factors for Alzheimer's disease prove useful in understanding the pathogenesis of Parkinson's disease?

Sutherland GT, Siebert GA, Kril JJ, Mellick GD.

J Alzheimers Dis. 2011;25(3):395-415. doi: 10.3233/JAD-2011-110026.

Oxidative genome damage and its repair in neurodegenerative diseases: function of transition metals as a double-edged sword

Hegde ML, Hegde PM, Rao KS, Mitra S.

J Alzheimers Dis. 2011;24 Suppl 2(0 2):183-98. doi: 10.3233/JAD-2011-110281.

A new hope for neurodegeneration: possible role of hydrogen sulfide

Gong QH, Shi XR, Hong ZY, Pan LL, Liu XH, Zhu YZ.

J Alzheimers Dis. 2011;24 Suppl 2:173-82. doi: 10.3233/JAD-2011-110128.

Role of advanced glycation on aggregation and DNA binding properties of α-synuclein

Padmaraju V, Bhaskar JJ, Prasada Rao UJ, Salimath PV, Rao KS.

J Alzheimers Dis. 2011;24 Suppl 2:211-21. doi: 10.3233/JAD-2011-101965.

Induced pluripotent stem cells and neurodegenerative diseases

Chen C, Xiao SF.

Neurosci Bull. 2011 Apr;27(2):107-14. doi: 10.1007/s12264-011-1147-9.

Brain illness and creativity: mechanisms and treatment risks

Flaherty AW.

Can J Psychiatry. 2011 Mar;56(3):132-43. doi: 10.1177/070674371105600303.

Pathogens and chronic or long-term neurologic disorders

Starakis I, Panos G, Koutras A, Mazokopakis EE.

Cardiovasc Hematol Disord Drug Targets. 2011 Mar 1;11(1):40-52. doi: 10.2174/187152911795945123.

Role of tissue C-reactive protein in atrial cardiomyocytes of patients undergoing catheter ablation of atrial fibrillation: pathogenetic implications

Narducci ML, Pelargonio G, Dello Russo A, Casella M, Biasucci LM, La Torre G, Pazzano V, Santangeli P, Baldi A, Liuzzo G, Tondo C, Natale A, Crea F.

Europace. 2011 Aug;13(8):1133-40. doi: 10.1093/europace/eur068. Epub 2011 Mar 29.

Myths and realities of continuous dopaminergic stimulation

Pirtošek Z.

Psychiatr Danub. 2011 Mar;23(1):80-3.

Factors associated with cognitive impairment in patients with Parkinson disease: an urban study

Rosdinom R, Fazli A, Ruzyanei NJ, Azlin B, Srijit D.

Clin Ter. 2011;162(1):23-9.

Neuroprotective effects of creatine

Beal MF.

Amino Acids. 2011 May;40(5):1305-13. doi: 10.1007/s00726-011-0851-0. Epub 2011 Mar 30.

Pedunculopontine stimulation from primate to patient

Pereira EA, Nandi D, Jenkinson N, Stein JF, Green AL, Aziz TZ.

J Neural Transm (Vienna). 2011 Oct;118(10):1453-60. doi: 10.1007/s00702-011-0631-8. Epub 2011 Mar 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias